Jeff Yass’s Elanco Animal Health ELAN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $1.8M | Sell |
73,200
-41,400
| -36% | -$957K | ﹤0.01% | 6734 |
|
|
2026
Q1 | $2.74M | Sell |
114,600
-26,300
| -19% | -$643K | ﹤0.01% | 5457 |
|
|
2025
Q4 | $3.19M | Buy |
140,900
+35,200
| +33% | +$766K | ﹤0.01% | 4775 |
|
|
2025
Q3 | $2.13M | Sell |
105,700
-1,029,600
| -91% | -$17.2M | ﹤0.01% | 5642 |
|
|
2025
Q2 | $16.2M | Buy |
1,135,300
+949,300
| +510% | +$11.1M | ﹤0.01% | 2246 |
|
|
2025
Q1 | $1.95M | Buy |
186,000
+48,900
| +36% | +$553K | ﹤0.01% | 5601 |
|
|
2024
Q4 | $1.66M | Sell |
137,100
-81,500
| -37% | -$1.07M | ﹤0.01% | 5720 |
|
|
2024
Q3 | $3.21M | Sell |
218,600
-134,500
| -38% | -$1.87M | ﹤0.01% | 4415 |
|
|
2024
Q2 | $5.1M | Sell |
353,100
-125,000
| -26% | -$2M | ﹤0.01% | 3408 |
|
|
2024
Q1 | $7.78M | Sell |
478,100
-15,500
| -3% | -$242K | ﹤0.01% | 2979 |
|
|
2023
Q4 | $7.35M | Buy |
493,600
+181,500
| +58% | +$2.06M | ﹤0.01% | 3082 |
|
|
2023
Q3 | $3.51M | Sell |
312,100
-37,600
| -11% | -$437K | ﹤0.01% | 4119 |
|
|
2023
Q2 | $3.52M | Buy |
349,700
+169,300
| +94% | +$1.57M | ﹤0.01% | 4105 |
|
|
2023
Q1 | $1.7M | Buy |
180,400
+72,500
| +67% | +$855K | ﹤0.01% | 5505 |
|
|
2022
Q4 | $1.32M | Sell |
107,900
-196,200
| -65% | -$2.45M | ﹤0.01% | 5578 |
|
|
2022
Q3 | $3.77M | Buy |
304,100
+227,700
| +298% | +$3.98M | ﹤0.01% | 3626 |
|
|
2022
Q2 | $1.5M | Sell |
76,400
-400
| -0.5% | -$9.47K | ﹤0.01% | 5537 |
|
|
2022
Q1 | $2M | Sell |
76,800
-596,600
| -89% | -$15.9M | ﹤0.01% | 5470 |
|
|
2021
Q4 | $19.1M | Buy |
673,400
+347,100
| +106% | +$10.8M | ﹤0.01% | 1903 |
|
|
2021
Q3 | $10.4M | Buy |
326,300
+195,300
| +149% | +$6.55M | ﹤0.01% | 2811 |
|
|
2021
Q2 | $4.54M | Sell |
131,000
-371,600
| -74% | -$12.3M | ﹤0.01% | 4205 |
|
|
2021
Q1 | $14.8M | Buy |
502,600
+264,000
| +111% | +$8.12M | ﹤0.01% | 2250 |
|
|
2020
Q4 | $7.32M | Buy |
238,600
+77,300
| +48% | +$2.36M | ﹤0.01% | 2887 |
|
|
2020
Q3 | $4.5M | Sell |
161,300
-228,100
| -59% | -$5.78M | ﹤0.01% | 3199 |
|
|
2020
Q2 | $8.35M | Sell |
389,400
-139,700
| -26% | -$3.09M | ﹤0.01% | 2357 |
|
|
2020
Q1 | $11.8M | Buy |
529,100
+43,500
| +9% | +$1.19M | ﹤0.01% | 1577 |
|
|
2019
Q4 | $14.3M | Sell |
485,600
-103,200
| -18% | -$2.8M | ﹤0.01% | 1735 |
|
|
2019
Q3 | $15.7M | Buy |
588,800
+148,300
| +34% | +$4.45M | 0.01% | 1532 |
|
|
2019
Q2 | $14.9M | Sell |
440,500
-452,600
| -51% | -$14.7M | 0.01% | 1523 |
|
|
2019
Q1 | $28.6M | Buy |
893,100
+854,400
| +2,208% | +$26.3M | 0.01% | 949 |
|
|
2018
Q4 | $1.22M | Buy |
+38,700
| New | +$1.27M | ﹤0.01% | 4315 |
|
Other funds holding ELAN
Jeff Yass's ELAN Position: Q2 2026 in Review
Jeff Yass increased its Elanco Animal Health (ELAN) stake by 76% in Q2 2026, buying an estimated $995K and bringing the position to 99,845 shares worth $2.46M. The position accounts for ﹤0.01% of the portfolio, ranked #6020.
Jeff Yass first reported a position in ELAN in Q4 2018 and has held it in 31 quarters since. The position peaked at $81M in Q1 2019. 518 funds tracked by Wall St. Rank hold ELAN as of Q2 2026.
- Jeff Yass held 99,845 shares of Elanco Animal Health worth $2.46M as of Q2 2026.
- Jeff Yass bought 43,037 Elanco Animal Health shares in Q2 2026, an estimated $995K.
- Elanco Animal Health made up ﹤0.01% of Jeff Yass's portfolio in Q2 2026, its #6020 holding.
- Jeff Yass first reported a position in Elanco Animal Health in Q4 2018 and has held it in 31 quarters since.
- Jeff Yass's Elanco Animal Health position peaked at $81M in Q1 2019.
- 518 funds tracked by Wall St. Rank held Elanco Animal Health as of Q2 2026.
Based on Susquehanna International Group's 13F filing for Q2 2026, filed 14 Aug 2026.